Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study

BMC Gastroenterology

Volumn 8, Issue , 2008, Pages

  Caballería, Llorenç ^a   Auladell, Ma Antonia ^a   Torán, Pere ^b   Pera, Guillem ^b   Miranda, Dolores ^c   Alumà, Alba ^c   Casas, José Dario ^c   Muñoz, Laura ^b   Sanchez, Carmen ^d   Tibau, Albert ^a   Birules, Marti ^c   Canut, Santiago ^a   Bernad, Jesús ^a   Aubà, Josep ^c   Aizpurua, Miren Maite ^c   Alcaraz, Enriqueta ^a  

^a Catalan Health Institute   (Spain)

^b Primary Healthcare Research Support Unit Barcelones Nord i Maresme   (Spain)

^c INSTITUT CATALÀ DE LA SALUT   (Spain)

^d Radiology Department   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ABUSE; ECHOGRAPHY; FEMALE; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; PHYSICAL EXAMINATION; POPULATION BASED CASE CONTROL STUDY; PRIMARY MEDICAL CARE; RISK FACTOR; SCORING SYSTEM; SMOKING; SPAIN; CASE CONTROL STUDY; CLINICAL TRIAL; ETHNOLOGY; FATTY LIVER; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIMARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; HUMANS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PRIMARY HEALTH CARE; RISK FACTORS; SPAIN;

EID: 54349099025     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-8-44     Document Type: Article

References (19)

1. Ludwig J Viggiano TR McGill DB Oh BJ Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease Mayo Clinic Proc 1980, 55(7):434-438.
2. Bedogni G Bellentani S Fatty liver: How frequent is it and why? Ann Hepatol 2004, 3:63-65. 15257248
3. Angulo P Nonalcoholic fatty liver disease N Engl J Med 2002, 346:1221-1331. 10.1056/NEJMra011775 11961152
4. Chitturi S Farrell GC Etiopathogenesis of nonalcoholic steatohepatitis Semin Liver Dis 2001, 21:27-41. 10.1055/s-2001-12927 11296694
5. Yourssef W McCullough AJ Diabetes mellitus, obesity, and hepatic steatosis Semin Gastrointest Dis 2002, 13:17-30. 11944630
6. Ford ES Giles WH Dietz WH Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey JAMA 2002, 287:356-359. 10.1001/jama.287.3.356 11790215
7. Diehl AM Fatty liver, hypertension and the metabolic syndrome Gut 2004, 53:923-924. 1774127 15194635 10.1136/gut.2003.037309
8. Pagano C Pacini G Musso G Gambino R Mecca F Depetris N Cassader M David E Cavallo-Perin P Rizzetto M Non-alcoholic steatohepatitis, insulin resistance and metabolic syndrome. Further evidence for an etiologic association Hepatology 2002, 35:367-72. 10.1053/jhep.2002.30690 11826410
9. Clark JM Brancati FL Diehl AM The prevalence and etiology of elevated aminotransferase levels in the United States Am J Gastroenterol 2003, 98:960-7. 10.1111/j.1572-0241.2003.07486.x 12809815
10. Bedogni G Miglioli L Masutti F Tiribelli C Marchesini G Bellentani S Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study Hepatology 2005, 42:44-52. 10.1002/ hep.20734 15895401
11. Caballería Ll Auladell AM Torán P Miranda D Aznar J Pera G Gil D Muñoz L Planas J Canut S Bernad J Aubà J Pizarro G Aizpurua MM Altaba A Tibau A Prevalence and factors associated with the presence of non alcoholic fatty liver disease in an apparently healthy adult population in primary care units BMC Gastroenterology 2007, 7:41. 2151951 17983472 10.1186/1471-230X-7-41
12. Dixon JB Bhatal PS O'Brien PE Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severity obese Gastroenterology 2001, 12191-100. 10.1053/gast.2001.25540 11438497
13. Angulo P Hui JM Marchesini G Bugianesi E George J Farrell GC Enders F Saksena S Burt AD Bida JP Lindor K Sanderson SO Lenzi M Adams LA Kench J Therneau TM Day CP The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 2007, 45:846-854. 10.1002/hep.21496 17393509
14. NHO Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO consultation Geneva: Department of Noncomunicable disease Surveillance, Word Health Organization 1999
15. Hills SA Balkau B Coppack SW Dekker JM Mari A Natali A Walker M Ferrannini E EGIR-RISC Study Group EGIR-RISC Study Group. The EGIR-RISC Study (the European Group for the study of Insulin Resistence: Relationship between insulin sensitivity and cardiovascular disease risc): I. Methodology and objectives Diabetologia 2004, 47:566-570. 10.1007/s00125-004-1335-5 14968294
16. Executive summary of the third report of the National Cholesterol Education (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults (Adults Treatment Panel III) JAMA 2001, 285:2486-2497. 10.1001/jama.285.19.2486 11368702
17. Alberti KG Zimmet P Shaw J Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation Diabet Med 2006, 23:469-80. 10.1111/j.1464-5491.2006.01858.x 16681555
18. Caballería J Rodés J Esteatohepatitis no alcohólica Med Clin (Barc) 2003, 120:670-675. 10.1157/13047319 12747817
19. Sanyal AJ AGA technical review on nonalcoholic fatty liver disease Gastroenterology 2002, 123:1705-1725. 10.1053/gast.2002.36572 12404245